- Home
- SRPT vs DBD Comparison
SRPT vs DBD Comparison
Compare SRPT & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | DBD |
|---|---|---|
| Founded | 1980 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2000 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SRPT | DBD |
|---|---|---|
| Price | $16.48 | $72.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 28 | 3 |
| Target Price | $25.56 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 2.0M | 294.0K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 677.27 |
| EPS | N/A | ★ 2.54 |
| Revenue | $2,198,237,000.00 | ★ $3,805,700,000.00 |
| Revenue This Year | N/A | $3.56 |
| Revenue Next Year | N/A | $3.25 |
| P/E Ratio | ★ N/A | $28.83 |
| Revenue Growth | ★ 15.58 | 1.46 |
| 52 Week Low | $10.42 | $34.88 |
| 52 Week High | $103.32 | $84.46 |
Technical Indicators
Market Signals| Indicator | SRPT | DBD |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 38.99 |
| Support Level | $15.51 | $67.60 |
| Resistance Level | $19.55 | $84.44 |
| Average True Range (ATR) | 0.87 | 2.75 |
| MACD | 0.11 | -1.24 |
| Stochastic Oscillator | 25.50 | 2.19 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About DBD Diebold Nixdorf Incorporated
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.